LataMed AI Corp. (OTC: LMED), a digital health and AI technology company, announced it has initiated an evaluation process to potentially integrate installment-based healthcare payment capabilities through Cashea, a leading buy-now-pay-later platform in Venezuela. The initiative aims to reduce upfront financial barriers for patients seeking private healthcare services, including consultations, diagnostics, and wellness programs, within the LataMed AI ecosystem.
The company believes improving payment accessibility could enhance patient engagement, increase healthcare utilization, and drive platform adoption. By addressing affordability challenges, LataMed AI aims to strengthen its position as a technology-enabled healthcare marketplace for patients, providers, and partners throughout Latin America. The potential Cashea integration aligns with the company’s broader strategy of combining AI, telehealth infrastructure, and digital payment solutions to create a scalable healthcare marketplace.
Dr. Kevin Rodan Levy, CEO of LataMed AI, stated: "We believe financial accessibility is a critical component of healthcare delivery. Our objective is to evaluate solutions that may help patients obtain timely medical care while expanding the reach of our ecosystem." The company has not yet entered a definitive agreement, and any integration remains subject to commercial discussions, technical requirements, and regulatory review.
LataMed AI focuses on emerging markets, leveraging AI for telehealth, care coordination, and analytics. The proposed payment integration could address a key barrier in private healthcare access, particularly in regions where upfront costs limit patient engagement. This move reflects a growing trend of fintech-healthcare partnerships aimed at improving affordability.
For more information, visit https://latamed.ai or review SEC filings at www.sec.gov.
